Thiophene compounds

Details for Australian Patent Application No. 2007317712 (hide)

Owner National Health Research Institutes

Inventors Liao, Jyh-Hsiung; Shia, Kak-Shan; Hung, Ming-Shiu; Chao, Yu-Sheng; Tai, Chia-Liang

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007317712

PCT Pub. Number WO2008/057681

Priority 60/848,761 02.10.06 US

Filing date 2 October 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 211/90 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

30 April 2009 PCT application entered the National Phase

  PCT publication WO2008/057681 Priority application(s): WO2008/057681

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317722-SNP detection and other methods for characterizing and treating bipolar disorder and other ailments

2007317707-Apparatus and method for application of a pharmaceutical to the tympanic membrane for photodynamic laser myringotomy